| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.24 | 4e-07 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |